Entity Common Stock, Shares Outstanding of Protagenic Therapeutics, Inc.\new from 11 Aug 2011 to 05 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Protagenic Therapeutics, Inc.\new quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Aug 2011 to 05 Mar 2026.
  • Protagenic Therapeutics, Inc.\new Entity Common Stock, Shares Outstanding for the quarter ending 05 Mar 2026 was 1,810,208, a 76% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Protagenic Therapeutics, Inc.\new Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 1,810,208 -5,715,473 -76% 05 Mar 2026 10-Q 09 Mar 2026 2026 Q3
Q4 2025 1,934,878 26 Nov 2025 10-Q 26 Nov 2025 2026 Q2
Q3 2025 1,914,937 -4,879,884 -72% 10 Sep 2025 10-QT 10 Sep 2025 2026 Q1
Q1 2025 7,525,681 +3,090,549 +70% 31 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 6,794,821 +2,359,689 +53% 11 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 4,467,266 +136,307 +3.1% 12 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 4,435,132 +113,687 +2.6% 29 Mar 2024 10-K/A 14 May 2024 2023 FY
Q3 2023 4,435,132 -12,850,129 -74% 14 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 4,330,959 -12,954,302 -75% 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 4,321,445 -12,931,833 -75% 31 Mar 2023 10-K/A 17 Apr 2023 2022 FY
Q3 2022 17,285,261 +329,444 +1.9% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 17,285,261 +585,610 +3.5% 09 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 17,253,278 +6,731,772 +64% 31 Mar 2022 10-K 07 Apr 2022 2021 FY
Q3 2021 16,955,817 12 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 16,699,651 +6,438,232 +63% 13 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 10,521,506 +260,087 +2.5% 17 Mar 2021 10-K 25 Mar 2021 2020 FY
Q4 2020 10,360,480 16 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 10,261,419 0 0% 17 Jun 2020 10-Q 18 Jun 2020 2020 Q1
Q1 2020 10,261,419 0 0% 27 Apr 2020 10-K 29 Apr 2020 2019 FY
Q3 2019 10,261,419 0 0% 14 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 10,261,419 0 0% 14 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 10,261,419 0 0% 29 Mar 2019 10-K 29 Mar 2019 2018 FY
Q3 2018 10,261,419 0 0% 08 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 10,261,419 0 0% 09 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 10,261,419 0 0% 30 Mar 2018 10-K 02 Apr 2018 2017 FY
Q3 2017 10,261,419 13 Nov 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 10,261,419 -389,738,581 -97% 07 Aug 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 10,261,419 -389,738,581 -97% 27 Mar 2017 10-K/A 08 May 2017 2016 FY
Q4 2016 8,307,915 17 Nov 2016 10-Q 17 Nov 2016 2016 Q3
Q2 2016 400,000,000 21 Jul 2016 10-Q 25 Jul 2016 2016 Q1
Q1 2016 400,000,000 0 0% 22 Feb 2016 8-K/A 12 Jul 2016 2015 FY
Q3 2015 400,000,000 0 0% 25 Sep 2015 10-K 25 Sep 2015 2015 FY
Q1 2015 400,000,000 11 May 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 400,000,000 06 Feb 2015 10-Q 06 Feb 2015 2015 Q2
Q3 2014 400,000,000 30 Sep 2014 10-K 14 Oct 2014 2014 FY
Q3 2011 7,205,719 08 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 7,012,287 11 Aug 2011 10-Q/A 07 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.